Skip to Content Skip to Search

Notices

Board Meeting Intimation - Un-Audited Financial Results for the second quarter and half year ended 30th September 2021

Trading window closure - October 2021

Presentation of Analyst/ Institutional Investor Meetings

Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations

Outcome of the Board Meeting

Un-Audited Financial Results for the first quarter ended 30th June 2021

Intimation of Record Date pursuant to Regulation 42 of the Securities and Exchange Board of India (LODR) Regulations, 2015

Outcome of meeting dt 18 May 2021

Press release - May 2021

Trading window closure

Outcome of Board Meeting

Un- Audited Financial Results for the quarter and nine months ended 31 st December 2020

Closure of Trading Window

Media release: Q2 FY20-21

Outcome of Board Meeting - October 2020

Un- Audited Financial Results for the quarter and six months ended 30th September 2020

Closure of Trading Window

Intimation of Schedule of Analyst / Institutional Investor Meetings under the Listing Regulations

Outcome of Board meeting - July 2020

Disclosure of Voting Results and Outcome of the 95th Annual General Meeting of the Company

Discontinuation of supply of Ranitidine products

Media release: Q4 FY19-20

Outcome of the Board Meeting

Outcome of Board Meeting March 2020

Press release - New MD appointment

Unaudited (Standalone and Consolidated) financial results for the third quarter and nine months ended 31st December 2019

Media release: Quarter ended 31st December 2019

Trading window closure February 2020

Board Meeting Intimation February 2020

Outcome of Board Meeting October 2019

Intimation of Schedule of Analyst / Institutional Investor Meetings under the Listing Regulations

Submission of Disclosure on Related Party Transactions

Trading window closure October 2019

Board Meeting Intimation October 2019

Update on the Company's Ranitidine Product

Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations - September 5, 2019

Approval of Sale of Company's land at Thane, Maharashtra 30/8 - August 30, 2019

Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations - August 12, 2019

Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations - August 12, 2019

Intimation of Schedule of Analyst/ Institutional Investor Meetings under the Listing Regulations - August 1, 2019

Outcome of Board Meeting July 2019

Outcome of Board Meeting - May 2019

Intimation of Book Closure 2019

Board Meeting Intimation - May 20, 2019

Change in Directorate - March 28, 2019

Board Meeting Intimation - February 4, 2019

Board Meeting Intimation Oct 2018

Publication of Add of Record Date for Bonus Issue of Shares

Record Date for Bonus Issue of Equity Shares

Board Meeting Intimation July 24, 2018

Board Meeting Intimation May 24, 2018

Board Meeting Intimation February 02, 2018

Change in Directorate - 25th October, 2017

Board Meeting Intimation October 25, 2017

Outcome of AGM 2017 and Voting Results

Board Meeting Intimation July 25, 2017

Publication of Evoting and Book Closure Notice

IEPF Notice May 24, 2017

Board Meeting Intimation May 19, 2017

Disclosures of castleton and GSK PTE

Change in Directorate - 7 April, 2017

Board Meeting Intimation 11-02-2017

Notice of Board Meeting - 27/10/2016

Outcome of AGM and Voting Results

Notice of Business Meeting - 28/07/2016

Publication of Notice regarding e-voting in Newspapers